Bridging Academia and Industry for Breakthrough Innovation

Join top VCs, academic innovators and biopharma leaders at the 2nd Annual BioCentury Grand Rounds - Europe in Amsterdam, Sept. 23-25, 2026.

Examine the latest advances in disease biology, therapeutic modalities and enabling technologies with the experts shaping the future of medicine

Explore how to make R&D investible with experienced company-builders and early-stage investors

Debate how to overcome key bottlenecks in translation to bring breakthrough discoveries into the clinic

Schedule partnering meetings with VCs, pharma executives and leading academics

Interested in learning more about becoming a Presenting Company for Grand Rounds Europe in Amsterdam?
Learn More

Speakers

LinkedIn
Vanessa Carle, Ph.D.
Principal
Forbion
LinkedIn
Emer Cooke
Executive Director
The European Medicines Agency's (EMA)
LinkedIn
Karen Massey
CEO
argenx
LinkedIn
Luke O'Neill, Ph.D.
Professor of Biochemistry, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute
Trinity College
LinkedIn
James Sabry, M.D., Ph.D.
EVP & Chief Business Officer
BioMarin Pharmaceutical Inc.
LinkedIn
Oskar Slotboom
Managing Partner
BioGeneration Ventures (BGV)
Moreright-arrow

Why Should I Attend?

Discover cutting-edge research with commercial potential, connect with partners who can accelerate translation and explore new opportunities to expand your portfolio and pipeline.

Network, partner and debate with:

  • VCs and PEs
  • Biopharma R&D and BD&L Leaders
  • Biotech C-Suite
  • Academic Innovators
  • Financial Dealmakers

Share your Story on Stage

Are you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2026 to increase your visibility and drive partnering requests. Limited space - submit your nominations today.

Apply to Present >>

Deliver Thought Leadership

Share your insights, elevate your brand and position yourself as a peer in BioCentury's network of biopharma decision-makers.

Learn More >>